ID - exam 4 - Influenza and HSV Flashcards

1
Q

Influenza virus classification

A

RNA virus
Single stranded
Negative sense
Enveloped
Helical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

High risk groups for Influenza (H1N1)

A

Age: <5 (especially <2), and >65)
Pregnant women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Secondary complications of seasonal influenza (Listed in prevalence)

A

Sinusitis
Bronchitis
Otitis Media
Pneumonia
Rhinitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Order of Influenza replication

A

1 - Penetration
2 - Uncoating
3 - Reverse Transcription
4 - Integration
5 - Transcription
6 - Translation
7 - Assembly
8 - Packing
9 - Release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What step of Influenza replication does an M2 (matrix protein 2) Inhibitor work at?

A

M2 Inhibitors prevent step 2 from occurring (Uncoating)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are examples of M2 Inhibitors

A

Amantadine
Rimantadine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What step of Influenza replication does a VP (Vasopeptidase) Inhibitor work at?

A

VP inhibitors prevent Transcription from occurring (Step 5)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are some examples of VP inhibitors

A

Favipiravir
Baloxavir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What step of Influenza replication does an NA Inhibitor work at?

A

NA inhibitors work to prevent the release of the newly replicated virus in step 9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some examples of NA (Neuraminidase) inhibitors

A

Oseltamivir
Peramivir
Zanamivir
Laninamivir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Zanamivir brand name

A

Relenza

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Zanamivir treatment conditions

A
  • Pt must be at least 5 years for prophylactic treatment and at least 7 years old for treatment
  • Must have a positive influenza test
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Zanamivir dosage form

A

Intranasal or oral inhalation therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Zanamivir dosing

A

Inhale 10mg bid x5d
- Must initiate within 48 hours of developing symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Zanamivir cautionary statement

A

Use caution in patients with COPD/asthma - deteriorates respiratory function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Zanamivir viral targeting

A

Targets both Influenza A + B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Oseltamivir brand name

A

Tamiflu

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Oseltamivir viral targeting

A

Targets both Influenza A + B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Oseltamivir treatment conditions

A

Must be at least 1yr old for both prophy and Tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Oseltamivir adverse reactions

A
  • Nausea, vomiting, diarrhea
  • Abdominal pain
  • Headache, dizziness, vertigo
  • Cough, insomnia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Oseltamivir dosing for CrCL < 30

A

CrCL < 30 –> decrease to 75mg QD instead of BID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Oseltamivir dosing for CrCL < 10

A

If CrCL is this low, use extreme caution as the drug has not been studied in these conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Oseltamivir dosing

A

Take 1 75mg capsule po bid ud

24
Q

Oseltamivir drug interactions

A

No dose adjustments required but increases Probenecid active metabolites two fold.

25
Peramivir brand name
Rapivab
26
Peramivir treatment conditions
At least 6 months old - Symptoms for at least 2 days
27
Peramivir dosing
600mg IV for adults infused over 15-30mins
28
Peramivir adverse reactions
- CNS depression - Diarrhea, constipation - Difficulty swallowing (Dysphagia)
29
Peramivir drug interactions
Limits vaccine effectiveness
30
What antiviral class is seeing growing resistance
NA inhibitors (Neuraminidase) is seeing small percents of increasing viral resistance
31
M2 inhibitors mechanism of action / antiviral usage
Interferes with replication of Type A Influenza (no effect on B)
32
M2 inhibitors indication (from symptom onset)
Administer within 48 hours to reduce severity and shorten the duration of the illness
33
Amantadine treatment conditions
Can be used in children and adults (within 48 hours of onset of symptoms)
34
Rimantadine treatment conditions
Can be used in adults as long as administered within 48 hours of symptom onset
35
M2 inhibitor adverse events
Prevalence of both insomnia and dizziness - 5-10% in Amantadine - 1-3% in Rimantadine
36
Why should m2 inhibitors be avoided in the current day?
Rapidly growing resistance in the early 2000s where we saw an exponential growth from 2003 flu season to 2005/6 - (1.7%, 1.9%, 14.5% and 92.3% resistance each year)
37
Baloxavir brand name
Xofluza
38
Baloxavir dosing
80mg po QD (40mg if less than 80kg)
39
Baloxavir drug interactions
Magnesium and other metal chelators - Also interacts with efficacy of vaccines
40
HSV-1 infection location
Trigeminal ganglia
41
HSV-2 infection location
Sacral Ganglia
42
Acyclovir targeting
Herpes > Varicella > CMV
43
Acyclovir dosing
- 20% bioavailability for 200mg dose - 10% for 800mg dose
44
Acyclovir adverse reactions
CNS depression Renal dysfunction Bone marrow
45
Acyclovir drug interactions
Probenecid Zidovudine
46
Valacyclovir targeting
Targets all HSV-1/2, VZV, and CMV (including shingles and recurrent)
47
Valtrex adverse reactions
TTP and HUS - Thrombotic Thrombocytopenic Purpura - Hemolytic Uremic Syndrome
48
Valtrex drug interactions
CYP450 enzymes Probenecid
49
Gancyclovir targeting
CMV > Herpes and Varicella
50
Gancyclovir dosing
IV only - biooavailability <20%
51
Gancyclovir adverse reactions
90% renal elimination - Bone marrow - CNS depression - Pancreatitis and multiple organ failure
52
Gancyclovir drug interactions
Probenecid Zidovudine Nephrotoxicity
53
Cidofovir targeting
CMV > Herpes - Mainly for retinitis in AIDS
54
Cidofovir adverse events
Renal elimination - Need fluid pre and post infusion - Administered IV only
55
Foscarnet targeting
CMV and HSV - Effective against acyclovir resistant HSV - IV only
56
Foscarnet drug interactions
nephrotoxic
57
Foscarnet adverse reactions
bone marrow and renal Hypokalemia and magnesia